Dr Reddy’s lines up semaglutide launch, builds biosimilars pipeline
Move comes even as pricing pressure and regulatory complexity continue to weigh on global pharmaceutical markets.
Move comes even as pricing pressure and regulatory complexity continue to weigh on global pharmaceutical markets.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
